Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
6.76
+0.24 (3.68%)
Jun 24, 2025, 4:00 PM - Market closed
Bioventus Market Cap
Bioventus has a market cap or net worth of $448.58 million as of June 25, 2025. Its market cap has increased by 2.45% in one year.
Market Cap
448.58M
Enterprise Value
791.90M
1-Year Change
2.45%
Ranking
Category
Stock Price
$6.76
Market Cap Chart
Since the IPO on February 11, 2021, Bioventus's market cap has decreased from $713.47M to $448.58M, a decrease of -37.13%. That is a compound annual growth rate of -10.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2025 | 432.65M | -36.96% |
| Dec 31, 2024 | 686.36M | 106.84% |
| Dec 29, 2023 | 331.83M | 105.22% |
| Dec 30, 2022 | 161.69M | -81.23% |
| Dec 31, 2021 | 861.26M | 20.71% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 691.83B |
| Johnson & Johnson | 364.09B |
| AbbVie | 324.59B |
| Novo Nordisk | 309.67B |
| UnitedHealth Group | 272.76B |
| Abbott Laboratories | 231.85B |
| Novartis AG | 229.25B |
| AstraZeneca | 218.15B |